← Back to Search

SweetGoals App for Type 1 Diabetes

N/A

Waitlist Available

Led By Catherine Stanger, Ph.D.

Research Sponsored by Trustees of Dartmouth College

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must use a glucometer or continuous glucose monitor compatible with Glooko.

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up +12 months

Awards & highlights

Study Summary

This trial will test an app and web intervention designed to help young adults with Type 1 diabetes better manage their blood sugar levels. The app provides self-monitoring tools and goal-setting assistance, while the web intervention offers health coaching and incentives for adherence.

Who is the study for?

This trial is for young adults with Type 1 diabetes who have had the condition for over 18 months and an A1c level of at least 7.5%. They must have seen their diabetes doctor in the last six months and use a glucose monitor compatible with Glooko. It's not for pregnant or breastfeeding individuals, those with severe illnesses like cystic fibrosis, severe cognitive issues, psychiatric conditions that affect participation, other types of diabetes, or if they're on certain meds that affect blood sugar.Check my eligibility

What is being tested?

The study tests a digital intervention called SweetGoals app aimed at improving blood sugar control in Type 1 diabetics. Everyone gets the core app features focused on self-monitoring and goal setting. Additionally, it will evaluate whether incentives for sticking to treatment plans and web-based health coaching can further improve outcomes.See study design

What are the potential side effects?

Since this trial involves using an app along with coaching and incentives rather than medication or medical procedures, there are no direct side effects as typically associated with drugs or surgery. However, participants may experience stress or frustration related to technology use or lifestyle changes encouraged by the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I use a Glooko-compatible glucose monitoring device.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ +12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~+12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and +12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HbA1c

Secondary outcome measures

Glucose

Problem solving

Trial Design

4Treatment groups

Experimental Treatment

Group I: App plus IncentivesExperimental Treatment2 Interventions

SweetGoals app + incentives=yes + coaching=no

Group II: App plus Coaching plus IncentivesExperimental Treatment3 Interventions

Sweetgoals app + incentives=yes + coaching=yes

Group III: App plus CoachingExperimental Treatment2 Interventions

Sweetgoals app + incentives=no + coaching=yes

Group IV: App onlyExperimental Treatment1 Intervention

Sweetgoals app only

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Coaching

2016

Completed Phase 3

~5600

Incentives

2018

Completed Phase 2

~1970

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,314,766 Total Patients Enrolled

Trustees of Dartmouth CollegeLead Sponsor

23 Previous Clinical Trials

10,385 Total Patients Enrolled

Catherine Stanger, Ph.D.Principal Investigator - Trustees of Dartmouth College

Trustees of Dartmouth College

2 Previous Clinical Trials

126 Total Patients Enrolled

Media Library

SweetGoals app Clinical Trial Eligibility Overview. Trial Name: NCT04646473 — N/A

Type 1 Diabetes Research Study Groups: App only, App plus Incentives, App plus Coaching, App plus Coaching plus Incentives

Type 1 Diabetes Clinical Trial 2023: SweetGoals app Highlights & Side Effects. Trial Name: NCT04646473 — N/A

SweetGoals app 2023 Treatment Timeline for Medical Study. Trial Name: NCT04646473 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts for this trial still ongoing?

"Yes, clinicaltrials.gov confirms that this trial is actively recruiting people to participate in the study. Initially posted on April 29th 2021 and last updated February 15th 2022, 300 patients are being recruited from a single medical centre."

Answered by AI

How many individuals are participating in this clinical experiment?

"Affirmative. Current data from clinicaltrials.gov confirms that this medical research, initially posted on April 29th 2021, is actively recruiting participants. 300 individuals are necessary for the trial and can be found at a single site."

Answered by AI

Can those under 70 years of age partake in the trial?

"This investigation is recruiting individuals who are between the age of 19 and 29."

Answered by AI

Am I eligible to be a participant in this clinical experiment?

"This research has a targeted enrolment of 300 individuals aged between 19 and 29 years old who suffer from both diabetes and autoimmune diseases. To qualify, participants must also have an A1C value of at least 7.5%, be diagnosed with type 1 diabetes for over 18 months, report visiting their doctor managing T1D within the last 6 months, and use either a glucometer or CGM that is compatible with Glooko."

Answered by AI